OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 8 results.
Search:

SKU Category Vector Description Price Delivery
SC325409 Human cDNA pCMV6-Neo GRIN2A (untagged)-Human glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A), transcript variant 3 NM_001134408.1 $1010 Immediate
RC226377 Human ORF PS100001 GRIN2A (Myc-DDK-tagged)-Human glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A), transcript variant 3 $800 5-6 weeks
RC226377L1 Human ORF PS100064 Lenti-ORF clone of GRIN2A (Myc-DDK-tagged)-Human glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A), transcript variant 3, (10ug) $980 7-8 weeks
RC226377L1V Human ORF PS100064 Lenti ORF particles, GRIN2A (Myc-DDK-tagged)-Human glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A), transcript variant 3, 200ul, >10^7 TU/mL $1380 10-11 weeks
RC226377L2 Human ORF PS100071 Lenti-ORF clone of GRIN2A (mGFP-tagged)-Human glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A), transcript variant 3, (10ug) $1080 7-8 weeks
RC226377L2V Human ORF PS100071 Lenti ORF particles, GRIN2A (mGFP-tagged)-Human glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A), transcript variant 3, 200ul, >10^7 TU/mL $1520 10-11 weeks
RG226377 Human ORF PS100010 GRIN2A (GFP-tagged) - Human glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A), transcript variant 3 $890 5-6 weeks
/ UTR pMirTarget 3`UTR clone of glutamate receptor ionotropic N-methyl D-aspartate 2A (GRIN2A) transcript variant 3 for miRNA target validation NM_001134408.1 $510 3-4 weeks
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title